Orca Bio has pulled together $250 million in new financing for the commercial launch of its treatment for complications from allogeneic stem cell transplants.
The money comes in part from two of Orca’s most recent …
Read More from Endpoints News
Orca adds $250M in financing to back launch of T cell therapy
